TeraFold Biologics is Biotechnology in United States that focus on medical diagnostics business. Founded in 2012. They cover business area such as developer, an integrate computational platform, pre-clinical validation, biologic drug, novel protein scaffold, application, novel therapeutic, medical diagnostic, end, engineering and production service, healthcare professional, cancer, neurodegenerative disease.
2012
( 12 years old in 2024 )
Medical Diagnostics
-
237 Kearny Street
Suite 268
San Francisco, CA 94108
United States
Private
developeran integrate computational platformpre-clinical validationbiologic drugnovel protein scaffoldapplicationnovel therapeuticmedical diagnosticendengineering and production servicehealthcare professionalcancerneurodegenerative disease
* We use standard office opening hours in near TeraFold Biologics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
TeraFold Biologics is Biotechnology business from United States that founded in 2012 (12 years old in 2024), TeraFold Biologics business is focusing on Medical Diagnostics.
TeraFold Biologics headquarter office and corporate office address is located in 237 Kearny Street Suite 268 San Francisco, CA 94108 United States.
TeraFold Biologics was founded in United States.
In 2024, TeraFold Biologics is currently focus on medical diagnostics sector.
Above is snippet of Google Trends for "medical diagnostics" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with TeraFold Biologics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
